17 mg ml tirzepatide Flex-Dose 3 Injectable 10 mg/mL FDA approves tirzepatide, Eli Lilly's

doi:10.1016/j.jacc.2017.10.064 78

Talk About Any History Of Serious Mental Illness Before You Start Discuss that history with your prescriber before beginning tirzepatide or other GLP-1 drugs, if you have a history of: Major depressive disorder Bipolar disorder Post-traumatic stress disorder Past suicidal thoughts People with severe depression or past suicidal ideation need closer monitoring during medication start and dose changes

Any papers resulting from these two trials do not appear to be indexed in major global databases like PubMed, and its not clear if they were ever published in peer-reviewed journals

Josh took the time to explain to us lab results and make necessary changes